Country Report Card

Senegal

Total population, 2018 (UN Population Division) 15,854,323
Surviving Infants (surviving to 1 year per year), 2018 (UN Population Division) 530,303
Child mortality rate (deaths < 5 years per 1000 live births), 2018 (Global Health Observatory) 43.6
Gross National Income (per capita, current US$), 2017 (World Bank) 950
No. of districts/territories, 2018 (JRF) 76.0
Total expenditure on health per capita (PPP Intl $), 2015 (Global Health Observatory) 97.0
Gov. exp. on Routine Immunization (US$), 2017 (JRF) 10,176,155
country flag

COUNTRY DATA

Senegal

COMMITMENTS INDICATORS 2015 2016 2017 2018 2019 2020
Governance Is the NITAG fully functional? Data not available Data not available Data not available Yes Yes Yes
Has the country established a NITAG? Data not available Data not available Data not available Yes Yes Yes
Domestic funding Government domestic funding for health as % of GDP 1.26 0.00 0.00 0.00 0.00 0.00
Government funding as % of total immunization funding 11.00 67.00 76.00 44.00 35.00 56.99
Equity Has the country reported district-level stock-out of the DTP or MCV vaccine? No No No No No No
Does the country conduct vaccine impact assessments for at least one newly-introduced vaccine? Data not available Data not available Data not available Yes Data not available Data not available
Proportion of districts with 80% or more MCV1 coverage 63.00 79.00 74.00 53.00 84.00 78.00
Proportion of districts with 80% or more DTP3 coverage 68.00 80.00 84.00 51.00 90.00 80.00
Effectiveness and efficiency Has the country sustained DTP3 coverage of 90% or more for at least 3 years? (2017-2019) No
Has the country sustained MCV1 coverage of 90% or more for at least 3 years? (2017-2019) No
Has the country sustained DTP3 coverage of 90% or more for at least 3 years (2018-2020)? Yes
Has the country sustained MCV1 coverage of 90% or more for at least 3 years (2018-2020)? No
Surveillance Non-measles febrile rash illness rate 5.20 5.04 3.38 2.20 3.70 1.80
NP-AFP rate 3.04 3.01 2.64 2.00 2.96 2.13
Coverage and VPD elimination DTP1 coverage 94.00 96.00 97.00 96.00 97.00 93.00
DTP3 coverage 89.00 93.00 93.00 92.00 95.00 91.00
MCV1 coverage 80.00 93.00 90.00 86.00 89.00 88.00
MCV2 coverage 54.00 57.00 59.00 62.00 68.00 69.00
OPV3 coverage 85.00 92.00 91.00 85.00 89.00 84.00
IPV1 coverage 81.00 72.00 0.00 82.00 92.00 90.00
Has the country introduced HPV vaccine? No No No Yes Yes Yes
Has the country introduced the Hepatitis B birth dose? No No Yes Yes Yes Yes
Has the country eliminated MNT? Yes Yes Yes Yes Yes Yes
Has the country eliminated Measles? No
Progress on polio Polio transition plan submitted? Yes
Did the country have any cases of WPV or cVDPV from 2015-2018? No
Did the country have any cases of WPV or cVDPV in 2019? No
Did the country have any cases of WPV or cVDPV in 2020? No
cVDPV cases 0.00 0.00 0.00 0.00 0.00 0.00
Immunization research Does the country have immunization research activities within the current cMYP? (2020) Yes
Does the country currently have a comprehensive Multi-Year Plan (cMYP) for immunization? (2020) Yes
Advocacy and political will Did the country observe African Vaccination Week or World Immunization Week? Yes No Yes No
Vaccine development and production Does the country currently manufacture vaccines? Yes
Has the country committed to manufacture vaccines in the next 5 years? Yes
Does the country have a national strategy or plan to manufacture vaccines? Yes
Has the country committed to vaccine manufacturing at the highest level? Yes
Has the country established (and/or is working to establish) a tech transfer hub? No
Has the country set aside funding specifically for local manufacture of vaccines? Yes
Does the country have regulatory capacity at level 3 or higher, sufficient to oversee vaccine manufacturing? No
Met Target  
Approaching Target  
Off Target  
No Report